Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiorella Magani

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Experimental Biology|April 23, 2016
Predation risk modifies behaviour by shaping the response of identified brain neuronsFiorella Magani, Tomas Luppi, Jesus Nuñez, et al.
Molecular Cancer Research : MCR|August 17, 2017
Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer VulnerabilitiesFiorella Magani, Stephanie O Peacock, Meghan A Rice, et al.
Molecular Systems Biology|August 16, 2018
Identification of an oncogenic network with prognostic and therapeutic value in prostate cancerFiorella Magani, Eric R Bray, Maria J Martinez, et al.
Science Translational Medicine|June 28, 2019
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancerNing Zhao, Stephanie O Peacock, Chen Hao Lo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Experimental Biology|April 23, 2016
Predation risk modifies behaviour by shaping the response of identified brain neuronsFiorella Magani, Tomas Luppi, Jesus Nuñez, et al.
Molecular Cancer Research : MCR|August 17, 2017
Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer VulnerabilitiesFiorella Magani, Stephanie O Peacock, Meghan A Rice, et al.
Molecular Systems Biology|August 16, 2018
Identification of an oncogenic network with prognostic and therapeutic value in prostate cancerFiorella Magani, Eric R Bray, Maria J Martinez, et al.
Science Translational Medicine|June 28, 2019
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancerNing Zhao, Stephanie O Peacock, Chen Hao Lo, et al.
Pageof 1